Kayexalate

• CAS Number:

  37349-16-9

• UNSPSC Description:

  Kayexalate, a cation-exchange resin, is an orally active plasma potassium inhibitor. Kayexalate can be used in the research of hyperkalemia[1][2].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/kayexalate.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [Kayexalate]

• References & Citations:

  [1]Harel Z, et al. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Am J Med. 2013 Mar;126(3):264.e9-24. |[2]J G Linakis, et al. Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate. Acad Emerg Med. 1997 Mar;4(3):175-8. |[3]Linakis JG, et al. Sodium polystyrene sulfonate treatment for lithium toxicity: effects on serum potassium concentrations. Acad Emerg Med. 1996 Apr;3(4):333-7.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported